Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

PDE

Items 31-40 of 55

Page
per page
  1. Irsogladine
    B1593 Irsogladine
    Summary: PDE4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥12.80 mg/mL
  2. Milrinone
    B1386 Milrinone
    Target: Phosphodiesterases (PDEs)
    Summary: PDE-3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥8.2 mg/mL
  3. Pimobendan hydrochloride
    B1165 Pimobendan hydrochloride
    Summary: Selective inhibitor of PDE3
      Soluble in DMSO
  4. Anagrelide HCl
    A4352 Anagrelide HCl
    Summary: Thrombocytopenic agent
      insoluble in EtOH; insoluble in H2O; ≥4.9 mg/mL
  5. S- (+)-Rolipram
    A4349 S- (+)-Rolipram
    Summary: CAMP-specific PDE4 inhibitor
      insoluble in H2O; ≥13.9 mg/mL
  6. Aminophylline
    A4346 Aminophylline
    Target: Phosphodiesterases (PDEs)
    Summary: Pan-PDE inhibitor
      ≥13.48 mg/mL
  7. Dyphylline
    A4343 Dyphylline
    Summary: Pan-PDE inhibitor
      ≥17.17 mg/mL
  8. Pimobendan
    A4340 Pimobendan
    Target: Phosphodiesterases (PDEs)
    Summary: Selective PDE3 inhibitor.Ca2+ channel sensitizer
      insoluble in H2O; ≥16.2 mg/mL
  9. Cilostazol
    A4337 Cilostazol
    Summary: PDE3 inhibitor
      insoluble in H2O; ≥15.4 mg/mL
  10. Avanafil
    A4334 Avanafil
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL

Items 31-40 of 55

Page
per page